will allow a limit to the dissemination of the newborn viruses onto the tissue cell
culture and to have a transmission of the infection only to the closest cells. This way
of viral expansion led to the creation of lysis plaque within the tissue culture, which
ultimately will allow for counting the initial number of viruses applied in the
suspension. This is possible for a viral concentration, which allows for the visual or
microscopic counting of the lysis plaque.
The method assumes that only one virus infects one cell which might introduce a
bias. The case of several defective incomplete viruses entering the same cell and
self-complementing cannot be ruled out. Therefore, false positives are possible for
such assays.
TCID50- Tissue Culture Infectious Dose 50 uses a similar principle of ap-
plying a suspension of the virus at different concentrations onto a plated tissue
culture. In this case, the diffusion of the newborn viruses is not limited to inducing
several cycles or replications on the same plated culture. Ultimately the whole
culture should be infected and lysed. Therefore, the read-out of such assays is
evaluating the cytopathic effect of a virus suspension. Such an assay lasts between
4 to 7 days [4]. The test is commonly performed on 96-well plates with replicates to
evaluate the percent of tissue cultures that have been infected after several potential
replication cycles. Thus, the wells that are infected are counted, among the wells
where the tissue culture is healthy. A statistical analysis is performed to determine
Negative Stain Transmission Electron Microscopy (NSTEM)
Extracellular vesicles
Influenza viral particle
Influenza virus like particles
Clarified supernant
Sucrose cushion purified supernant
FIGURE 8.2 Negative Staining Transmission Electron Microscopy (NSTEM) observation
of viral preparations. A − Sucrose cushion and sucrose gradient purified preparation of
influenza virus, extracellular vesicles, or influenza virus like particles. B – Immunogold
labeling of sucrose cushion and sucrose gradient purified preparation of influenza virus.
C – Several purification steps of culture supernatant.
Analytics and virus production processes
207